List of works - Francois Grand-Maison

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

scientific article published on 5 December 2014

Comparative efficacy of switching to natalizumab in active multiple sclerosis

scientific article

Contribution of different relapse phenotypes to disability in multiple sclerosis.

scientific article published on 7 April 2016

Defining reliable disability outcomes in multiple sclerosis

scientific article published on 10 September 2015

Defining secondary progressive multiple sclerosis

scientific article published on 7 July 2016

Geographical variations in sex ratio trends over time in multiple sclerosis.

scientific article

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

scientific article published on 28 September 2016

Increasing age at disability milestones among MS patients in the MSBase Registry

scientific article published on 14 April 2012

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

scientific article published on April 2017

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

scientific article published on 5 June 2015

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

scientific article

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

scientific article

Predictors of disability worsening in clinically isolated syndrome.

scientific article published on 27 March 2015

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Risk of relapse phenotype recurrence in multiple sclerosis.

scientific article

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

scientific article published on 20 October 2014

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

scientific article published on 18 October 2013

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

scientific article published on 21 July 2015

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

scientific article published in September 2017

List of works by Francois Grand-Maison

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Comparative efficacy of switching to natalizumab in active multiple sclerosis

Contribution of different relapse phenotypes to disability in multiple sclerosis.

Defining reliable disability outcomes in multiple sclerosis

Defining secondary progressive multiple sclerosis

Geographical variations in sex ratio trends over time in multiple sclerosis.

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Increasing age at disability milestones among MS patients in the MSBase Registry

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

Predictors of disability worsening in clinically isolated syndrome.

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Risk of relapse phenotype recurrence in multiple sclerosis.

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.